Connecticut General Statutes
Chapter 420b - Dependency-Producing Drugs
Section 21a-283. (Formerly Sec. 19-483). - Analytical tests for presence of controlled drugs or alcohol. Standards and procedures. Convictions constituting prior offense. Imposition of cost when analysis performed.

(a) The Division of Scientific Services within the Department of Emergency Services and Public Protection shall have primary responsibility for analysis of materials believed to contain controlled drugs, or of blood or urine believed to contain alcohol, for purposes of criminal prosecutions pursuant to this chapter; provided nothing herein shall be construed to preclude the use for such analyses of the services of other qualified toxicologists, pathologists and chemists, whether employed by the state or a municipality or a private facility or engaged in private practice, if such toxicologists, pathologists and chemists are engaged in operation of or employed by laboratories licensed by the Commissioner of Public Health or the Commissioner of Consumer Protection pursuant to section 21a-246. A laboratory of the United States Bureau of Narcotics is not required to be licensed under this section if it is approved by the Division of Scientific Services within the Department of Emergency Services and Public Protection.

(b) The Division of Scientific Services within the Department of Emergency Services and Public Protection shall establish the standards for analytical tests to be conducted with respect to controlled drugs, or with respect to body fluids believed to contain alcohol, by qualified professional toxicologists and chemists operating under the division's direction and shall have the general responsibility for supervising such analytical personnel in the performance of such tests. The original report of an analysis made by such analytical personnel of the Division of Scientific Services or by a qualified toxicologist, pathologist or chemist of a laboratory of the United States Bureau of Narcotics shall be signed and dated, either by hand or electronically, by the analyst actually conducting the tests and shall state the nature of the analytical tests or procedures, the identification and number of samples tested and the results of the analytical tests. A copy of such report certified by the analyst shall be received in any court of this state as competent evidence of the matters and facts therein contained at any hearing in probable cause, pretrial hearing or trial. If such copy is to be offered in evidence at a trial, the attorney for the state shall send a copy thereof, by certified mail, to the attorney of the defendant who has filed an appearance of record or, if there is no such attorney, to the defendant if such defendant has filed an appearance pro se, and such attorney or defendant, as the case may be, shall, not later than five days after the receipt of such copy, notify the attorney for the state, in writing, if such attorney or defendant intends to contest the introduction of such certified copy. No such trial shall commence until the expiration of such five-day period and, if such intention to contest has been filed, the usual rules of evidence shall obtain at such trial.
(c) In the case of any person charged with a violation of any provision of sections 21a-243 to 21a-279, inclusive, who has been previously convicted of a violation of the laws of the United States or of any other state, territory or the District of Columbia, relating to controlled drugs, such previous conviction shall, for the purpose of sections 21a-277 and 21a-279, be deemed a prior offense.
(d) In addition to any fine, fee or cost that may be imposed pursuant to any provision of the general statutes, the court shall impose a cost of fifty dollars upon any person convicted of a violation of this chapter if an analysis of a controlled substance in relation to the conviction was performed by or at the direction of the chief toxicologist of the Department of Public Health or the Division of Scientific Services within the Department of Emergency Services and Public Protection. Any cost imposed under this subsection shall be credited to the appropriation for the Department of Emergency Services and Public Protection and shall not be diverted for any other purpose than the provision of funds for the Division of Scientific Services.
(1967, P.A. 555, S. 38; 1969, P.A. 753, S. 20; 1971, P.A. 164; P.A. 73-681, S. 18, 29; P.A. 74-186, S. 6, 12; P.A. 77-614, S. 323, 610; P.A. 87-129, S. 10; P.A. 90-261, S. 13; P.A. 93-381, S. 9, 39; P.A. 95-257, S. 12, 21, 58; P.A. 99-218, S. 8, 16; June 30 Sp. Sess. P.A. 03-6, S. 146(c); P.A. 04-189, S. 1; P.A. 11-51, S. 134; P.A. 17-87, S. 2.)
History: 1969 act made previous provisions Subsec. (c) and added Subsecs. (a) and (b) re duties of chief toxicologist; 1971 act amended Subsec. (b) to replace “blood or urine” with “body fluids”, to add reference to analyses made by qualified toxicologists, pathologists or chemists of U.S. Bureau of Narcotics laboratories, to allow use of report copies certified by analyst as evidence in any court proceeding, replacing provision re use of report in conjunction with testimony of health department toxicologist, and added provision detailing use of report copies and obtaining them; P.A. 73-681 added reference to laboratories licensed by commissioner of consumer protection in Subsec. (a); P.A. 74-186 specified that Bureau of Narcotics laboratories need not be licensed if approved by chief toxicologist in Subsec. (a); P.A. 77-614 replaced department and commissioner of health with department and commissioner of health services, effective January 1, 1979; Sec. 19-483 transferred to Sec. 21a-283 in 1983; P.A. 87-129 substituted reference to Sec. 21a-243 for Sec. 21a-242, repealed by the same act; P.A. 90-261 amended Subsec. (b) to make technical changes and added Subsec. (d) re the imposition of a $50 cost upon certain convicted persons when an analysis of a controlled substance was performed and the crediting of such cost to the appropriation for the department of health services for the purpose of providing funds for the chief toxicologist; P.A. 93-381 replaced department and commissioner of health services with department and commissioner of public health and addiction services, effective July 1, 1993; P.A. 95-257 replaced Commissioner and Department of Public Health and Addiction Services with Commissioner and Department of Public Health, effective July 1, 1995; P.A. 99-218 replaced the chief toxicologist of the Department of Public Health with the Division of Scientific Services within the Department of Public Safety, and, in Subsec. (d), added the division as a source of an analysis of a controlled substance, effective July 1, 1999; June 30 Sp. Sess. P.A. 03-6 replaced Commissioner of Consumer Protection with Commissioner of Agriculture and Consumer Protection, effective July 1, 2004; P.A. 04-189 repealed Sec. 146 of June 30 Sp. Sess. P.A. 03-6, thereby reversing the merger of the Departments of Agriculture and Consumer Protection, effective June 1, 2004; pursuant to P.A. 11-51, “Department of Public Safety” was changed editorially by the Revisors to “Department of Emergency Services and Public Protection”, effective July 1, 2011; P.A. 17-87 amended Subsec. (b) by adding provision re analyst to sign and date by hand or electronically and making technical changes.
Annotations to former section 19-483:
Cited. 169 C. 692. Testimony of chief toxicologist, based partly on personal observation and partly on test by chemist under his supervision, properly admitted. 172 C. 593.
Subsec. (b):
Objection must be raised in court; effective date of 1971 amendment. 166 C. 439. The use in evidence of report of the toxicologist in lieu of personal testimony is allowed unless defendant, having been notified in accordance with the procedure under statute, objects in writing to the use of the report. 168 C. 395. Cited. Id., 520. Written report is admissible in lieu of testimony of analyst when there has been compliance with requirements of section. 169 C. 416. Failure of state to comply with mailing provision of Subsec. did not require granting of a new trial. 172 C. 16. Cited. 181 C. 562.

Structure Connecticut General Statutes

Connecticut General Statutes

Title 21a - Consumer Protection

Chapter 420b - Dependency-Producing Drugs

Section 21a-240. (Formerly Sec. 19-443). - Definitions.

Section 21a-241. (Formerly Sec. 19-449). - Prior regulations continued.

Section 21a-242. (Formerly Sec. 19-450a). - Schedules of controlled substances. Exceptions.

Section 21a-243. (Formerly Sec. 19-451). - Regulations. Schedules of controlled substances.

Section 21a-244. (Formerly Sec. 19-451a). - Regulations re storage and retrieval of prescription information.

Section 21a-244a. - Drug records maintained on electronic data processing systems or media systems. Electronic identifiers. Regulations.

Section 21a-245. (Formerly Sec. 19-452). - Manufacture, sale, administering of restricted substances regulated.

Section 21a-246. (Formerly Sec. 19-453). - License to manufacture, wholesale, supply, compound, etc. Exception. License fees. License to possess and supply marijuana.

Section 21a-247. (Formerly Sec. 19-454). - Qualifications of applicant for license.

Section 21a-248. (Formerly Sec. 19-456). - Sale or dispensing of controlled drugs by licensed manufacturer or wholesaler. Records; orders. Scope of uses limited.

Section 21a-249. (Formerly Sec. 19-457). - Prescription requirements.

Section 21a-250. (Formerly Sec. 19-458). - Rights and duties of pharmacist.

Section 21a-251. (Formerly Sec. 19-459). - Dispensing of controlled substances by hospitals, infirmaries or clinics.

Section 21a-252. (Formerly Sec. 19-460). - Prescription and dispensing of controlled substances by certain practitioners. Surrender of unused substances by patients. Prescription, dispensing and administering of controlled substances to immediate fam...

Section 21a-253. - Possession of marijuana pursuant to a prescription.

Section 21a-254. (Formerly Sec. 19-461). - Designation of restricted drugs or substances by regulations. Records required by chapter. Electronic prescription drug monitoring program. Information reporting of diabetes drugs and devices.

Section 21a-254a. - Appointment of prescription drug monitoring working group. Membership.

Section 21a-255. (Formerly Sec. 19-462). - Penalty for failure to make, furnish or keep records, statements or information. General penalty.

Section 21a-256. (Formerly Sec. 19-463). - Labeling of package or container of controlled substances.

Section 21a-257. (Formerly Sec. 19-464). - Person receiving narcotic drug to keep it in original container. Exceptions. Class D misdemeanor.

Section 21a-258. (Formerly Sec. 19-465). - Exceptions concerning possession and control.

Section 21a-259. (Formerly Sec. 19-466). - Common nuisances. Receivership of rental housing property development.

Section 21a-260. (Formerly Sec. 19-467a). - Narcotics control section in Department of Consumer Protection.

Section 21a-261. (Formerly Sec. 19-468). - Inspection of records. Entry on premises. Warrants and arrests.

Section 21a-262. (Formerly Sec. 19-469). - Commissioner's authority and duties re controlled substances. When seizing authority may destroy. Disposal by long-term care facilities, outpatient surgical facilities and home health care agencies.

Section 21a-263. (Formerly Sec. 19-469a). - Power of commissioner to receive and destroy drug paraphernalia. Records.

Section 21a-264. (Formerly Sec. 19-470). - Notice to licensing boards of violations by licensees.

Section 21a-265. (Formerly Sec. 19-471). - Inspection of prescriptions, orders, records and stocks restricted to government officers and third-party payors. Confidentiality.

Section 21a-266. (Formerly Sec. 19-472). - Prohibited acts.

Section 21a-267. (Formerly Sec. 19-472a). - Penalty for use, possession or delivery of drug paraphernalia associated with a controlled substance other than cannabis. Immunity.

Section 21a-268. (Formerly Sec. 19-473). - Misrepresentation of substance as controlled substance. Exemption.

Section 21a-269. (Formerly Sec. 19-474). - Burden of proof of exception, excuse, proviso or exemption.

Section 21a-270. (Formerly Sec. 19-474a). - Drug paraphernalia: Factors to be considered by court or other authority in determination.

Section 21a-271. (Formerly Sec. 19-474b). - Severability of provisions concerning drug paraphernalia.

Section 21a-272. (Formerly Sec. 19-475). - Preparations which may be sold and dispensed. Exceptions.

Section 21a-273. (Formerly Sec. 19-476). - Substances exempt under federal law.

Section 21a-274. (Formerly Sec. 19-477). - Cooperation in enforcement of law.

Section 21a-274a. - Drug enforcement grant program. Safe neighborhoods grant program. Community mobilization antidrug grant program.

Section 21a-275. (Formerly Sec. 19-478). - Revocation or suspension of licenses by commissioner.

Section 21a-276. (Formerly Sec. 19-479). - Discretion of commissioner to issue warning.

Section 21a-277. (Formerly Sec. 19-480). - Penalty for illegal manufacture, distribution, sale, prescription, dispensing.

Section 21a-278. (Formerly Sec. 19-480a). - Penalty for illegal manufacture, distribution, sale, prescription or administration by non-drug-dependent person.

Section 21a-278a. - Penalty for illegal manufacture, distribution, sale, prescription or administration.

Section 21a-278b. - Penalty for illegal manufacture, distribution, sale, prescription administration or growing of cannabis or cannabis products.

Section 21a-278c. - (Note: This section is effective July 1, 2023.) Cultivation of cannabis plants in consumer's primary residence.

Section 21a-279. (Formerly Sec. 19-481). - Penalty for illegal possession of a controlled substance other than cannabis. Alternative sentences. Immunity.

Section 21a-279a. - Limits for legal possession of cannabis. Penalty for illegal possession. Calculation of amount and equivalencies.

Section 21a-279b. - Construction of public act 15-2 of the June special session* re violations of section 21a-279.

Section 21a-279c. - Exceptions for seeking medical assistance for medical distress from use of cannabis.

Section 21a-279d. - Cannabis given by one consumer to another.

Section 21a-280. (Formerly Sec. 19-481a). - Breathing of anesthesia not violation.

Section 21a-281. (Formerly Sec. 19-481b). - Presumption of psychological dependence on volatile substances.

Section 21a-282. (Formerly Sec. 19-482). - No prosecution where federal action has been taken.

Section 21a-283. (Formerly Sec. 19-483). - Analytical tests for presence of controlled drugs or alcohol. Standards and procedures. Convictions constituting prior offense. Imposition of cost when analysis performed.

Section 21a-283a. - Court authorized to depart from imposing mandatory minimum sentence.

Section 21a-284 and 21a-285. (Formerly Secs. 19-484 and 19-485). - Suspension of prosecution for treatment for drug dependence; dismissal of charges. Order for treatment in addition to penalties on conviction; penalty for unauthorized departure from...

Section 21a-286. - Agreements for distribution and administration of opioid antagonists. Regulations.

Section 21a-254. (Formerly Sec. 19-461). *(See end of section for - Designation of restricted drugs or substances by regulations. Records required by chapter. Electronic prescription drug monitoring program. Information reporting of diabetes drugs an...

Section 21a-301 to 21a-305. (Formerly Secs. 19-504a, 19-504c to 19-504e, - Definitions. Regulations. Inspections of: Institutional pharmacies, pharmacist's drug rooms and dispensing outpatient facilities; correctional and juvenile training institutio...

Section 21a-307. (Formerly Sec. 19-504i). - Definitions re dispensing of drugs.